Malignant Pleural Mesothelioma Apr 2026
Initial screenings include Chest X-rays and CT scans, often revealing pleural thickening or pleural effusion (fluid buildup).
The standard first-line treatment for decades has been Cisplatin combined with Pemetrexed. malignant pleural mesothelioma
Research into BAP1-deficient tumors and angiogenesis inhibitors (like Bevacizumab) is ongoing. Initial screenings include Chest X-rays and CT scans,
A non-invasive device that uses electric fields to disrupt cancer cell division. Prognosis and Future Outlook which dictate treatment response and survival:
Historically, the median survival rate for MPM has been 12 to 18 months. However, the landscape is shifting:
MPM is categorized into three primary histological subtypes, which dictate treatment response and survival: